ResMed (RMD)
(Delayed Data from NYSE)
$211.66 USD
+0.75 (0.36%)
Updated Jun 10, 2024 04:00 PM ET
After-Market: $211.79 +0.13 (0.06%) 4:38 PM ET
1-Strong Buy of 5 1
D Value B Growth D Momentum C VGM
Brokerage Reports
0 items in cart
ResMed Inc. [RMD]
Reports for Purchase
Showing records 1 - 20 ( 528 total )
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Optimized Entry and Exit Levels for RMD 21224
Provider: Stock Traders Daily
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Resuming Coverage - Initiating Coverage
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Optimized Entry and Exit Levels for RMD 12224
Provider: Stock Traders Daily
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Optimized Entry and Exit Levels for RMD 1224
Provider: Stock Traders Daily
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department